Capricor Therapeutics Inc (CAPR)
18.72
+0.14
(+0.75%)
USD |
NASDAQ |
Nov 05, 11:37
Capricor Therapeutics Profit Margin (Quarterly): -277.0% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -277.0% |
| March 31, 2024 | -199.6% |
| December 31, 2023 | -6.30% |
| September 30, 2023 | -103.3% |
| June 30, 2023 | -188.0% |
| March 31, 2023 | -260.1% |
| December 31, 2022 | -804.3% |
| September 30, 2022 | -400.3% |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | -2.33K% |
| March 31, 2021 | -12.62K% |
| December 31, 2020 | -7.22K% |
| September 30, 2020 | -23.19K% |
| June 30, 2020 | -6.99K% |
| March 31, 2020 | -1.12K% |
| December 31, 2019 | -661.6% |
| September 30, 2019 | -1.13K% |
| June 30, 2019 | -498.7% |
| March 31, 2019 | -1.09K% |
| December 31, 2018 | -503.0% |
| September 30, 2018 | -1.89K% |
| June 30, 2018 | -1.02K% |
| Date | Value |
|---|---|
| March 31, 2018 | -917.7% |
| December 31, 2017 | |
| September 30, 2017 | -873.0% |
| June 30, 2017 | -348.4% |
| March 31, 2017 | -416.3% |
| December 31, 2016 | -660.9% |
| September 30, 2016 | -780.2% |
| June 30, 2016 | -514.4% |
| March 31, 2016 | -468.1% |
| December 31, 2015 | -367.1% |
| September 30, 2015 | -319.5% |
| June 30, 2015 | -342.7% |
| March 31, 2015 | -333.7% |
| December 31, 2014 | -185.1% |
| September 30, 2014 | -148.2% |
| June 30, 2014 | -147.3% |
| March 31, 2014 | -116.2% |
| December 31, 2013 | |
| September 30, 2013 | |
| June 30, 2013 | |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | |
| June 30, 2012 | |
| March 31, 2012 | -394.8% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-23.19K%
Minimum
Sep 2020
-6.30%
Maximum
Dec 2023
-3.76K%
Average
-661.6%
Median
Dec 2019
Profit Margin (Quarterly) Benchmarks
| Abbott Laboratories | 15.48% |
| ResMed Inc | 25.43% |
| enVVeno Medical Corp | -- |
| Regenxbio Inc | -237.7% |
| AIM ImmunoTech Inc | -3.67K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -261.3% |
| Return on Assets | -60.85% |
| Return on Invested Capital | -261.3% |
| Operating Margin (Quarterly) | -291.9% |
| Return on Net Operating Assets | -285.1% |